ABU DHABI: Cleveland Clinic Abu Dhabi, part of the M42 network, has successfully completed 50 deep brain stimulation implants since it was introduced in the hospital in 2020. Being one of the leading hospitals in the UAE to provide this unique treatment option to Parkinson’s disease patients, Cleveland Clinic Abu Dhabi reaffirms its commitment to pioneering innovative solutions and advancing medical technology in the UAE and wider region.
Deep brain stimulation is a sophisticated surgical procedure that involves implanting electrodes in specific areas of the brain, which deliver controlled electrical impulses to modify abnormal brain activity responsible for Parkinson’s disease symptoms. Electrodes are connected to a device, known as an implantable pulse generator (IPG), which is placed beneath the skin on the chest. Once activated, the IPG emits continuous electrical pulses to the targeted areas of the brain, effectively modulating abnormal neural activity and reducing the debilitating symptoms associated w
ith Parkinson’s disease.
Dr. Florian Roser, Chair of the Neurological Institute at Cleveland Clinic Abu Dhabi, stated, ‘In the realm of Parkinson’s disease treatment, the advent of deep brain stimulation stands as a revolutionary beacon of hope. This groundbreaking procedure not only alleviates symptoms but fundamentally transforms the lives of patients, offering newfound possibilities and restoring a sense of control in the face of this daunting neurological challenge. As a provider of deep brain stimulation in the UAE, we take pride in offering cutting-edge treatments, reaffirming our dedication to elevating the standard of care for Parkinson’s patients.’
As a destination for world-class complex care, Cleveland Clinic Abu Dhabi’s offering of deep brain stimulation surgery has revolutionized patient care in the UAE, significantly reducing the need for patients to travel abroad for specialized treatment. In fact, patients traveling from the region and beyond seek treatment at the hospital due to the availab
ility of this cutting-edge technology.
The journey toward this remarkable achievement began three years ago when Cleveland Clinic Abu Dhabi collaborated with Cleveland Clinic in the U.S to introduce deep brain stimulation surgery for patients in the UAE.
Parkinson’s disease is a neurodegenerative condition that shows most commonly as slowness in movements, shaking of the hand (tremor), and muscle stiffness. The prevalence of the disease is rising rapidly, making it the fastest-growing neurological condition globally. According to the World Health Organization, the prevalence of Parkinson’s disease has doubled in the past 25 years, with global estimates showing over 8.5 million individuals with the disease in 2019. Parkinson’s disease is a progressive condition, and regular follow-up appointments are essential to maintain optimal symptom control. Cleveland Clinic Abu Dhabi provides specialized treatment, including programming adjustments and a multidisciplinary approach to ensure that patients continue to ex
perience the benefits of deep brain stimulation.
Source: Emirates News Agency